SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017435
Filing Date
2022-11-10
Accepted
2022-11-10 16:24:26
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q enfn-20220930x10q.htm   iXBRL 10-Q 1520696
2 EX-31.1 enfn-20220930xex31d1.htm EX-31.1 12015
3 EX-31.2 enfn-20220930xex31d2.htm EX-31.2 11261
4 EX-32.1 enfn-20220930xex32d1.htm EX-32.1 5055
5 EX-32.2 enfn-20220930xex32d2.htm EX-32.2 5062
  Complete submission text file 0001558370-22-017435.txt   5437973

Data Files

Seq Description Document Type Size
6 EX-101.SCH enfn-20220930.xsd EX-101.SCH 37817
7 EX-101.CAL enfn-20220930_cal.xml EX-101.CAL 44954
8 EX-101.DEF enfn-20220930_def.xml EX-101.DEF 196783
9 EX-101.LAB enfn-20220930_lab.xml EX-101.LAB 348621
10 EX-101.PRE enfn-20220930_pre.xml EX-101.PRE 278726
55 EXTRACTED XBRL INSTANCE DOCUMENT enfn-20220930x10q_htm.xml XML 766694
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40949 | Film No.: 221377638
SIC: 7372 Services-Prepackaged Software